Search

Search Results

• 

  Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

  M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

  278-285

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.682

  2947

  PDF: 1446
• 

  New approved drugs for psoriatic arthritis

  F.M. Perrotta, E. Lubrano

  57-64

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.873

  3407

  PDF: 2352
• 

  Radiologists and rheumatologists on performing and reporting shoulder ultrasound: from disagreement to consensus

  G. Filippou, A. Adinolfi, A. Delle Sedie, E. Filippucci, A. Iagnocco, F. Porta, L. M. Sconfienza, S. Tormenta, V. Di Sabatino, V. Picerno, B. Frediani

  233-239

  06-11-2014

  https://doi.org/10.4081/reumatismo.2014.739

  1984

  PDF: 1457
• 

  Manual therapy and therapeutic exercise in the treatment of osteoarthritis of the hip: a systematic review

  A. Romeo, S. Parazza, M. Boschi, T. Nava, C. Vanti

  63-74

  27-05-2013

  https://doi.org/10.4081/reumatismo.2013.63

  7828

  PDF: 4073
• 

  Efficacy of bosentan in the treatment of Raynaud’s phenomenon in patients with systemic sclerosis never treated with prostanoids

  S. Parisi, M. Bruzzone, C. Centanaro Di Vittorio, A. Laganà, C.L. Peroni, E. Fusaro

  286-291

  17-03-2014

  https://doi.org/10.4081/reumatismo.2013.691

  2901

  PDF: 1317
• 

  Bradykinin and its role in osteoarthritis

  L. De Falco, A. Fioravanti, M. Galeazzi, S. Tenti

  97-104

  23-07-2013

  https://doi.org/10.4081/reumatismo.2013.97

  3511

  PDF: 1974
• 

  Effectiveness of cognitive behavioral therapy in the treatment of fibromyalgia syndrome: a meta-analytic literature review

  A. Minelli, A. Vaona

  151-157

  19-07-2012

  https://doi.org/10.4081/reumatismo.2012.151

  2588

  PDF: 1547

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  https://doi.org/10.4081/reumatismo.2010.248

  1367

  PDF: 741

• PO:08:126 | Use of upadacitinib in real-life: the experience of Calabrian rheumatology Vincenzo Raimondo¹, Maurizio Caminiti², Pietro Gigliotti³, Giuseppe Varcasia⁴, Massimo L'Andolina⁵, Domenico Olivo⁶, Roberta Pellegrini⁷, Pietro Muto⁸, Marilena Calabria⁹, Laura Massaro¹⁰, Jessica Maria El Luppino¹¹, Salvatore De Bonis¹², Giuseppa Pagano Mariano², Stefania Sorbara³, Virginia Caira⁴, Mariateresa Cirillo⁵, Caterina Bruno⁹, Clodoveo Ferri¹¹ | ¹UOC di Reumatologia, Dipartimento SCIAC, Sapienza Università di Roma; ²Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; ³UOC Medicina Interna e Nefrologia, Dipartimento MeSVA, Università degli Studi di L'Aquila; ⁴UniCamillus, San Camillo Università Internazionale di Scienze della Salute di Roma, Italy; ⁵Ambulatorio di Reumatologia, Ospedale di Tropea, Tropea, Italy; ⁶ASP Crotone, Ambulatorio di Reumatologia, Crotone, Italy; ⁷Ambulatorio di Reumatologia, Ospedale Annunziata di Cosenza, Cosenza, Italy; ⁸Ambulatorio di Reumatologia, Ospedale di Paola, Paola, Italy; ⁹Ambulatorio di Reumatologia, SOC di Medicina Interna, AOU Dulbecco, Catanzaro, Italy; ¹⁰Ambulatorio di Reumatologia, Ospedale di Praia a Mare, Praia a Mare, Italy; ¹¹Casa di Cura Madonna dello Scoglio, Reparto di Reumatologia, Cotronei, Italy - Affiliazione 12: Ambulatorio di Reumatologia, ospedale di Acri, Acri, Italy  

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2143

  131

• PO:05:069 | Risankizumab efficacy in peripheral and axial involvement: monocentric experience Roberta Foti¹, Ylenia Dal Bosco¹, Giorgio Amato¹, Elisa Visalli¹, Francesco De Lucia¹, Gabriella Paolí¹, Rosario Foti¹. | ¹UOSD Reumatologia AOU Policlinico G. Rodolico-S. Marco, Catania, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2012

  133
• 

  Italian Society of Rheumatology recommendations for the management of gout

  M. Manara, A. Bortoluzzi, M. Favero, I. Prevete, C.A. Scirè, G. Bianchi, C. Borghi, M. A. Cimmino, G. M. D'Avola, G. Desideri, G. Di Giacinto, M. Govoni, W. Grassi, A. Lombardi, M. Marangella, M. Matucci Cerinic, G. Medea, R. Ramonda, A. Spadaro, L. Punzi, G. Minisola

  4-21

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.4

  6016

  PDF: 1617
• 

  Influenza vaccination is safe and effective in patients suffering from fibromyalgia syndrome

  J. N. Ablin, V. Aloush, A. Brill, M. Berman, M. Barzilai, D. Caspi, M. Mandelboim, D. Levartovsky, A. Polachek, Y. Wolman, D. Paran, M. Barkagan, O. Elkayam

  57-61

  16-09-2015

  https://doi.org/10.4081/reumatismo.2015.823

  2474

  PDF: 1133
• 

  Far infrared emitting plaster in knee osteoarthritis: a single blinded, randomised clinical trial

  GL. Bagnato, G. Miceli, M. Atteritano, N. Marino, GF. Bagnato

  388-394

  20-12-2012

  https://doi.org/10.4081/reumatismo.2012.388

  5286

  PDF: 2818
• 

  Intra-articular therapy with tumor necrosis factor-α antagonists: an update

  S. Bello, C. Bonali, L. Serafino, C. Rotondo, N. Terlizzi, G. Lapadula

  257-263

  14-03-2014

  https://doi.org/10.4081/reumatismo.2013.721

  2806

  PDF: 1349
• 

  Efficacy of high-dose methylprednisolone pulses in a child with noninfectious persistent pleuropericarditis revealing systemic juvenile idiopathic arthritis

  G. De Rosa, A. De Nisco, M. Piastra, P. Valentini, D. Rigante

  114-115

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.876

  1687

  PDF: 1541

• PO:33:203 | Efficacy and safety of rituximab in eosinophilic fasciitis: report of three cases and systematic literature review Andrea Benini¹, Beatrice Moccaldi¹, Marco Binda¹, Anna Cuberli¹, Mariangela Favaro¹, Andrea Doria¹, Elisabetta Zanatta¹ | ¹UOC Reumatologia, Azienda Ospedale, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2210

  169

• PO:07:101 | Efficacy and safety of methotrexate in a cohort of patients affected by early-onset rheumatoid arthritis: a monocentric real-life study Carlo Cauli¹, Martina Favretti², Giulio Dolcini², Vincenzo Ferraro¹, Cristina Iannuccelli³, Fabrizio Conti¹, Manuela Di Franco¹ | ¹UOC Reumatologia, Dipartimento di scienze cliniche internistiche anestesiologiche e cardiovascolari, Sapienza, Roma; ²Dipartimento di Medicina Molecolare, La Sapienza, Roma; ³UOC Reumatologia, AOU Policlinico Umberto I, La Sapienza, Roma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2138

  147

• Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca (KCS) in patients with primary Sjögren’s syndrome (SS) not responding to standard treatment with artificial tears

  P. Ostuni, M.E.C. Battista, A. Furlan

  119-124

  https://doi.org/10.4081/reumatismo.2005.119

  1091

  PDF: 2108
• 

  Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia

  K. Thieme, D.C. Turk

  275-285

  28-09-2012

  https://doi.org/10.4081/reumatismo.2012.275

  3503

  PDF: 3130
• 

  Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA)

  G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli

  126-136

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.913

  3357

  PDF: 2242

• PO:15:217 | Improved efficacy and safety outcomes in patients with systemic lupus erythematosus treated with belimumab vs. immunosuppressants, in addition to antimalarials and glucocorticoids: a post-hoc summary of five phase 3 trials Mariele Gatto¹, Karen H. Costenbader², Andreas Schwarting³, Julia Hn Harris⁴, Ciara O'Shea⁵, Roger A. Levy⁶, Andrea Doria⁷ | ¹Centro Accademico Reumatologia, Dipartimento Scienze Cliniche Biologiche, Università degli Studi Torino, Osp. Mauriziano, Italy; ²Brigham and Women's Hospital, Divisione di Reumatologia, Infiammazione e Immunità, Harvard Medical School, Boston, MA, USA; ³Università Johannes Gutenberg di Mainz, Centro medico universitario, Germany; ⁴GSK, Immunologia Biostatistica London, UK; ⁵GSK, Global Medical Affairs Reumatologia, Dublin, Ireland; ⁶GSK, Global Medical Affairs Collegeville, PA, USA; ⁷Divisione di Reumatologia, Dipartimento di Medicina, Università di Padova, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2160

  150
• 

  Psoriatic arthritis: imaging techniques

  A. Spadaro, E. Lubrano

  99-106

  05-06-2012

  https://doi.org/10.4081/reumatismo.2012.99

  2059

  PDF: 2042
• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3906

  PDF: 1313

• PO:04:054 | Clinical efficacy and drug retention rate of upadacitinib in patients with axial spondyloarthritis: results from a single-center observational study Simona Buonanno¹, Carla Gaggiano¹, Caterina Baldi¹, Marco Bardelli¹, Cristiana Barreca¹, Francesca Bellisai¹, Marta Fabbroni¹, Paolo Falsetti¹, Anna Paola Pata¹, Enrico Selvi¹, Jurgen Sota¹, Antonio Vitale¹, Luca Cantarini¹, Bruno Frediani¹, Stefano Gentileschi¹ | U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2130

  148
• 

  Management of cutaneous discomfort in patients with scleroderma: a clinical trial

  M. Muratore, L. Quarta, L. Raho, D. Costanza, S. Frisenda, F. Calcagnile, A. Grimaldi, E. Quarta, D. Carati, M. Guido, A. Zizza, G. Alessandrini

  240-247

  18-12-2013

  https://doi.org/10.4081/reumatismo.2013.240

  3732

  PDF: 1166

• PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato¹, Laura Coladonato¹, Marco Fornaro¹, Marlea Lavista¹, Daniele Sabella¹, Marco Capodiferro¹, Maria Morrone¹, Crescenzio Scioscia¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area Jonica^J, University of Bari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2161

  142

• 18 month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis

  Alberto Migliore, Sandro Tormenta, Umberto Massafra, Luis Severino Martin Martin, Emilia Carloni, Cristiano Padalino, Andrea Alimonti, Mauro Granata

  39-49

  https://doi.org/10.4081/reumatismo.2006.39

  1686

  PDF: 1196

• PO:24:063 | Interstitial lung disease in idiopathic inflammatory myopathy patients: efficacy and safety of nintedanib Giulia Buonsante^1|2|3, Giacomo De Luca^1|2|3, Veronica Batani^1|2, Lorenzo Dagna^1|2|3, Marco Matucci-Cerinic^1|2|3, Corrado Campochiaro^1|2|3 | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital Milano, Italy; ²Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital Milano, Italy; ³Vita-Salute San Raffaele University, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2350

  25

• Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis

  S. Bello, C. Bonali, L. Serafino, P. Di Giuseppe, A. Minosi, N. Terlizzi

  46-50

  https://doi.org/10.4081/reumatismo.2010.46

  1205

  PDF: 1394
• 

  Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis

  A. Spadaro, A. Scarno, A. Carboni, F.M. Perrotta, C. Catalano, E. Lubrano, G. Valesini

  134-137

  24-07-2013

  https://doi.org/10.4081/reumatismo.2013.134

  2857

  PDF: 827
• 

  Vitamin D and rheumatic diseases

  M. Rossini, D. Gatti, O. Viapiana, C. Caimmi, L. Idolazzi, E. Fracassi, S. Adami

  153-170

  28-07-2014

  https://doi.org/10.4081/reumatismo.2014.788

  4186

  PDF: 2150
• 

  Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial

  C. Benini, G. Rubino, G. Paolazzi, G. Adami, C. Caimmi, O. Viapiana, D. Gatti, M. Rossini

  22-11-2021

  https://doi.org/10.4081/reumatismo.2021.1394

  6109

  PDF: 1155

• PO:15:222 | Post-hoc analysis of the BeRLiSS-JS registry: efficacy of belimumab on thrombocytopenia Greta Hulej¹, Margherita Zen¹, Marisol Bracalenti¹, Francesca Bottazzi², Rossella De Angelis³, Giacomo Emmi⁴, Roberto Gerli⁵, Marcello Govoni⁶, Renato Lo Gullo⁷, Simone Negrini⁸, Luca Quartuccio⁹, Maurizio Rossini¹⁰, Carlo Salvarani¹¹, Paola Tomietto⁴, Angelo Vacca¹², Andrea Doria¹, Luca Iaccarino¹. | ¹Università degli Studi di Padova, Padova, Italy; ²Università degli Studi di Pavia, Pavia, Italy; ³Università Politecnica delle Marche, Ancona, Italy; ⁴Università degli Studi di Trieste, Trieste, Italy; ⁵Università degli Studi Perugia, Perugia, Italy; ⁶Università degli Studi di Ferrara, Ferrara, Italy; ⁷Università degli Studi di Catania, Catania, Italy; ⁸Università degli Studi di Torino, Torino, Italy; ⁹Università degli Studi di Udine, Udine, Italy; ¹⁰Università degli Studi di Verona, Verona, Italy; ¹¹Università degli Studi di Modena e Reggio Emilia, Modena, Italy; ¹²Università degli Studi di Bari .

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2042

  132

• Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

  G. Lapadula

  22-29

  https://doi.org/10.4081/reumatismo.2005.4s.22

  923

  PDF: 1161

• PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study Giuseppe Alvise Ramirez^1|2, Gabriele D Gallina¹, Chiara Calabrese^1|2, Serena Nannipieri^1|2, Marta Calatroni^3|4, Francesco Reggiani^3|4, Giovanni Benanti¹, Enrica Paola Bozzolo¹, Raffaele Ceniccola², Luca Moroni^1|2, Marco Matucci-Cerinic^1|2, Gabriella Moroni^3|4, Lorenzo Dagna^1|2 | ¹IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases Milan, Italy; ²Vita- Salute San Raffaele University Milan, Italy; ³IRCCS Humanitas Research Hospital, Nephrology and Dialysis Division Rozzano, Milan, Italy; ⁴Humanitas University, Department of Biomedical Sciences Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2334

  28

• Efficacy and safety of Amtolmetin Guacyl in the symptomatic treatment of the osteoarthritis

  G. Biasi, L. Moltoni, C. Acciai, S. Di Martino, R. Marcolongo

  145-150

  https://doi.org/10.4081/reumatismo.2001.145

  1139

  PDF: 780
• 

  Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: where do we stand and what may be the future?

  Beatrice Maranini, Roberta Foti, Moustapha Taha, Veronica Venturelli, Andrea Lo Monaco, Marcello Govoni

  29-01-2025

  https://doi.org/10.4081/reumatismo.2025.1754

  2241

  PDF: 428

  SUPPLEMENTARY MATERIAL: 166

• PO:16:227 | Anifrolumab for Systemic Lupus Erythematosus: Preliminary Safety and Efficacy Findings from the Italian Experience Paola Bizioli^1|2, Chiara Orlandi^1|2, Claudia Barison^1|2, Cesare Tomasi³, Alessia Caproli¹, Silvia Piantoni^1|2, Simona Signorini⁴, Emirena Garrafa⁴, Cecilia Nalli¹, Micol Frassi¹, Ilaria Cavazzana^1|2, Micaela Fredi^1|2, Franco Franceschini^1|2 | ¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia, Italy; ²Department of Clinical and Experimental Sciences, University of Brescia, Italy; ³Department of Clinical and Experimental Sciences, University of Brescia, Italy; ⁴Laboratory of Clinical Chemistry, Department of Molecular and Translational Medicine, University of Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2333

  37

• Tolerability, safety and efficacy of Iloprost infusion without peristaltic pump in systemic sclerosis

  M. Arreghini, P. Prudente, W. Maglione, C. Arnoldi, S. Tosi, A. Marchesoni

  140-144

  https://doi.org/10.4081/reumatismo.2001.140

  954

  PDF: 1209

• PO:08:116 | Rheumatoid nodulosis: incidence, clinical/instrumental description, and phenotypic correlations in patients with rheumatoid arthritis treated with b-DMARDs. A real-life analysis from a monocentric cohort Stefano Ruggiero¹, Elisa Montebelli³, Simone Bernardi², Marcello Natali⁴, Francesca Martelli¹, Alessandra Caula¹, Federica Landolfini¹, Gabriella Cucinotta¹, Sofia Giulianelli¹, Francesco Girelli² | ¹UOC Medicina Interna, Ospedale Morgagni-Pierantoni; Dipartimento di scienze Mediche e Chirurgiche Università di Bologna; ²UOS Reumatologia, Ospedale Morgagni-Pierantoni, Forlì; ³Università degli Studi di Bologna; ⁴UOC Radiologia, Ospedale Morgagni-Pierantoni, Forlì, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2141

  132
• 

  The Italian Society for Rheumatology guidelines for the treatment of patients with rheumatoid arthritis and interstitial lung disease

  Chiara Crotti, Nicola Ughi, Carlo Alberto Scirè, Fabrizio Luppi, Fabiola Atzeni, Silvia Bosello, Roberto Caporali, Marina Carotti, Greta Carrara, Giulia Cassone, Lorenzo Cavagna, Lucia Dardani, Enrico De Lorenzis, Gian Luca Erre, Angelo Fassio, Roberto Gerli, Sergio Alfonso Harari, Florenzo Iannone, Gianpiero Landolfi, Andrea Lo Monaco, Silvia Mancuso, Marco Matucci-Cerinic, Maria Antonietta Mazzei, Venerino Poletti, Massimo Radin, Davide Rozza, Fausto Salaffi, Stefano Salvioli, Gian Domenico Sebastiani, Silvia Tonolo, Carlo Vancheri, Andreina Manfredi, Marco Sebastiani

  10-11-2025

  https://doi.org/10.4081/reumatismo.2025.1865

  1499

  PDF: 122

• PO:37:269 | Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis Davide Bertelle, Riccardo Bixio, Francesco Pollastri, Maurizio Rossini, Angelo Fassio, Alessandro Giollo | Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2222

  144
• 

  Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients

  N.A.G. Gaafar, M. Aslani, Z. Aghazadeh, S.S. Mortazavi-Jahromi, A. Razavi, A. Mirshafiey

  93-102

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1235

  1199

  PDF: 766

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  https://doi.org/10.4081/reumatismo.2009.54

  1412

  PDF: 1120

• CO:11:3 | Belimumab for lupus nephritis patients with poor kidney function: a post-hoc analysis of the bliss-ln trial Giacomo Emmi^1|2, Ersilia Lucenteforte³, Giorgio Limoncella³, Emanuele Chiara^1|2, Marta Calatroni^4|5, Gabriella Moroni^4|5 | ¹Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; ²Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; ³Department of Statistics, Informatics and Applications Giuseppe Parenti, University of Florence, Florence, Italy; ⁴Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; ⁵Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2278

  15

• PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini¹, Luca Iaccarino¹, Federico Arru², Greta Hulej¹, Anna Giorgia Osele¹, Noemi Merra¹, Davide Ragno¹, Andrea Doria¹, Margherita Zen¹ | ¹UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; ²UO Medicina, ASL 3 Nuoro, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2162

  125

• PO:26:087 | Rituximab versus glucocorticoids for IgG4-related disease: a European retrospective multi-center study of 167 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Jasmin Mahajne¹, Veronica Batani¹, Lorenzo Dagna¹, Emanuel Della-Torre¹ | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale san Raffaele Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Stavanger, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University Munich, Munich Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2355

  47

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2366

  PDF: 901

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1219

  PDF: 1838

• PO:15:216 | Safety and Efficacy of a single dose of Rituximab to manage Pregnancy-Related Severe Flare of Systemic Lupus Erythematosus: A Case Report Eugenio Capparelli¹, Daniela Bompane¹, Eleonora Zaccara¹, Laura Castelnovo¹, Antonio Tamburello¹, Antonino Mazzone², Paola Faggioli¹ | ¹UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; ²UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2329

  25